Clinical Biomarker of Paclitaxel-induced Peripheral Neuropathy

Abroad (travel likely)Recruiting

Conditions

Chemotherapy-induced Peripheral Neuropathy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Odense University Hospital, Odense, Denmark
Contact: Study coordinator (Marianne Vogsen) · marianne.vogsen@rsyd.dk · +4550932282
University Hospital of Southern Denmark, Sønderborg, Sønderborg, Denmark
Contact: Study coordinator (Marianne Christensen) · marianne.christensen.onk@rsyd.dk · +4579973034
University Hospital of Southern Denmark, Vejle, Vejle, Denmark
Contact: Study coordinator (Lise Ventzel) · lise.ventzel@rsyd.dk · +4579406060

Study leads

Ditte Bork Iversen
Study Chair
University of Southern Denmark

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Scrambler Therapy for Chemotherapy-Induced Peripheral Neuropathy

Chemotherapy-induced Peripheral Neuropathy · CIPN - Chemotherapy-Induced Peripheral Neuropathy

Abroad (travel likely)Recruiting

Cleveland, United States

Physiologic Measure of VIPN

Chemotherapy-induced Peripheral Neuropathy

Abroad (travel likely)Recruiting

Washington D.C., United States

Relationship Between Great Toe Strength And Symptoms of Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Chemotherapy-induced Peripheral Neuropathy (CIPN) · Healthy

Abroad (travel likely)Recruiting

Gainesville, United States

Safety, Tolerability, and PK of AH-008 Following Single Ascending Dose in Healthy Subjects

Chemotherapy-induced Peripheral Neuropathy (CIPN)

Abroad (travel likely)RecruitingPHASE1

Salt Lake City, United States